Literature DB >> 6725657

Topical therapy of alopecia areata with squaric acid dibutylester.

P C Case, A J Mitchell, N A Swanson, E E Vanderveen, C N Ellis, J T Headington.   

Abstract

The efficacy of the topical allergen squaric acid dibutylester (SADBE) was investigated in the treatment of twenty-six patients with alopecia areata or alopecia totalis. The patients had their disease for a mean duration of 8.3 years (range, 3 months to 27 years). Sensitization was attempted with 2% SADBE in acetone. Five individuals could not be sensitized. The twenty-one sensitized patients were treated with topical applications of 0.001% to 1.0% SADBE in acetone adjusted to produce and maintain dermatitis for an average of 21 weeks. Eleven (52%) had excellent responses consisting of complete regrowth in six and cosmetically acceptable regrowth in five. The average treatment time for regrowth was 11 weeks (range, 5-20 weeks). Ten (48%) had no clinical response after an average of 19 weeks of therapy (range, 4-42 weeks). Topical SADBE is an effective therapy for some patients with long-standing alopecia areata.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6725657     DOI: 10.1016/s0190-9622(84)80091-2

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  2 in total

1.  Percutaneous penetration of squaric acid and its esters in hairless mouse and human skin in vitro.

Authors:  E F Sherertz; K B Sloan
Journal:  Arch Dermatol Res       Date:  1988       Impact factor: 3.017

2.  Comparative Study of Efficacy and Safety of Topical Squaric Acid Dibutylester and Diphenylcyclopropenone for the Treatment of Alopecia Areata.

Authors:  Anup K Tiwary; Dharmendra K Mishra; S S Chaudhary
Journal:  N Am J Med Sci       Date:  2016-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.